Filter
53
Filtered Results: 53
Text search:
L.
Fairlie
Featured
Recommendations
9
New Publications
11
Language
Document type
No document type
24
Guidelines
18
Studies & Reports
9
Manuals
1
Strategic & Response Plan
1
Countries / Regions
Ukraine
2
Global
2
South Africa
2
Brazil
2
Tajikistan
1
Thailand
1
Rwanda
1
Nigeria
1
Zimbabwe
1
Philippines
1
Haiti
1
Germany
1
Uganda
1
Eastern Europe
1
Russia
1
India
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Guidelines
5
Child Health
3
COVID-19
2
Child protection
2
Demograhic Health Surveys DHS
2
Women & Child Health
2
Studies & Reports
2
NCD
1
Cardiovascular Diseases
1
Drugs & Medical Equipment
1
Disabilities
1
Statistics
1
HIV & STI
1
Neonatal Care
1
Toolboxes
Children & Adolescents
4
Vaxzevria (Astra Zeneca)
4
HIV testing & services
3
Drug resistance
3
Children/Adolescents Mental Disorders
3
Infection Control General
3
Educational Settings
3
Workplace
3
Physical Distancing
3
ART Drug Resistance
2
Treatment & Prevention
2
Attention deficit hyperactivity disorder (ADHD)
2
Universal Health Coverage UHC and 90-90-90 Strategy
2
Drugs
1
General Reports
1
Clinical Aspects, Treatment & Prevention
1
Vaccination
1
Ukraine
1
Substance Use Disorders, Others
1
HIV testing & disclosure
1
General Studies & Reports
1
People who injecting Drugs
1
Adherence
1
Women's Mental Health
1
Russia
1
Treatment Guidelines
1
Clinical Guidelines
1
Prevention & Preparedness
1
Country specific documents
1
Global Impact: Socio-economic, health services, TB & HIV
1
Palliative Care
1
Gambling
1
Non-pharmaceutical interventions (NPIs)
1
TB/HIV
1
Ethics
1
Palliative Care
1
Booster Doses
1
Essential Medicines & Devices Lists
1
Risk Factors
1
Women
1
Substance Use Disorders & Addiction
1
Disease Prevention & Control
1
HIV and coinfection
1
TB/HIV Coinfection
1
Anxiety Disorders
1
Tajikistan
1
Reports & Studies Children HIV
1
Reports & Studies
1
Training & Capacity Building
1
Eastern Europe and central Asia
1
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
Up-to-date Literature review current through: Jan 2015. | This topic last updated: Jan 29, 2015.
Depress Anxiety. 2018 March ; 35(3): 195–208. doi:10.1002/da.22711.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
DHS Working Papers No. 94 - This study described the family planning initiatives in Rwanda and analyzed the 2005 and 2010 RDHS data to identify factors that contribute to the increase in contraceptive use. The Blinder-Oaxaca technique was used to decompose the contributions of women’s characterist...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Agenda item 5, UNAIDS/PCB (43)/18.
11-13 December 2018 | Geneva, Switzerland
UNAIDS Programme Coordinating Board
Issue date: 23 November 2018
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Consideraciones para aplicar y ajustar medidas de salud pública y sociales en el contexto de la COVID-19
recommended
orientaciones provisionales, 14 de junio de 2021
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
